Literature DB >> 26998284

Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells.

Hemant Sarin1.   

Abstract

For proper determination of the apoptotic potential of chemoxenobiotics in synergism, it is important to understand the modes, levels and character of interactions of chemoxenobiotics with cells in the context of predicted conserved biophysical properties. Chemoxenobiotic structures are studied with respect to atom distribution over molecular space, the predicted overall octanol-to-water partition coefficient (Log OWPC; unitless) and molecular size viz a viz van der Waals diameter (vdWD). The Log OWPC-to-vdWD (nm-1 ) parameter is determined, and where applicable, hydrophilic interacting moiety/core-to-vdWD (nm-1 ) and lipophilic incorporating hydrophobic moiety/core-to-vdWD (nm-1 ) parameters of their part-structures are determined. The cellular and sub-cellular level interactions of the spectrum of xenobiotic chemotherapies have been characterized, for which a classification system has been developed based on predicted conserved biophysical properties with respect to the mode of chemotherapeutic effect. The findings of this study are applicable towards improving the effectiveness of existing combination chemotherapy regimens and the predictive accuracy of personalized cancer treatment algorithms as well as towards the selection of appropriate novel xenobiotics with the potential to be potent chemotherapeutics for dendrimer nanoparticle-based effective transvascular delivery.

Entities:  

Keywords:  cell membrane perturbomodulation; cell membrane receptor-mediated pressuromodulation; charge; dendrimer nanoparticle; functional group; hydrophilicity; lipophilicity; molecular imaging; predicted OWPC-to-vdWD ratio; predicted overall octanol-to-water partition coefficient; predicted van der Waals diameter; theranostic probe

Year:  2015        PMID: 26998284      PMCID: PMC4774464          DOI: 10.3892/mco.2015.714

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  195 in total

1.  Imaging of caspase-3 activation in HeLa cells stimulated with etoposide using a novel fluorescent probe.

Authors:  S Mizukami; K Kikuchi; T Higuchi; Y Urano; T Mashima; T Tsuruo; T Nagano
Journal:  FEBS Lett       Date:  1999-06-25       Impact factor: 4.124

2.  Neuroprotective and antioxidant properties of FKBP-binding immunophilin ligands are independent on the FKBP12 pathway in human cells.

Authors:  Ken-ichi Tanaka; Naoko Fujita; Youichirou Higashi; Norio Ogawa
Journal:  Neurosci Lett       Date:  2002-09-20       Impact factor: 3.046

3.  Limited in vitro efficacy of CYP17A1 inhibition on human castration resistant prostate cancer.

Authors:  Takeo Kosaka; Akira Miyajima; Yota Yasumizu; Yasumasa Miyazaki; Eiji Kikuchi; Mototsugu Oya
Journal:  Steroids       Date:  2014-08-20       Impact factor: 2.668

Review 4.  Molecular mechanisms of caspase regulation during apoptosis.

Authors:  Stefan J Riedl; Yigong Shi
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

5.  Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

Authors:  N Udagawa; N Takahashi; E Jimi; K Matsuzaki; T Tsurukai; K Itoh; N Nakagawa; H Yasuda; M Goto; E Tsuda; K Higashio; M T Gillespie; T J Martin; T Suda
Journal:  Bone       Date:  1999-11       Impact factor: 4.398

6.  Short course dexamethasone treatment following injury inhibits bleomycin induced fibrosis in rats.

Authors:  W A Dik; R J McAnulty; M A Versnel; B A E Naber; L J I Zimmermann; G J Laurent; S E Mutsaers
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

7.  p53 abnormalities in different subtypes of human sarcomas.

Authors:  A Andreassen; T Oyjord; E Hovig; R Holm; V A Flørenes; J M Nesland; O Myklebost; J Høie; O S Bruland; A L Børresen
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

8.  Staurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathways.

Authors:  Xu Dong Zhang; Susan K Gillespie; Peter Hersey
Journal:  Mol Cancer Ther       Date:  2004-02       Impact factor: 6.261

9.  Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100.

Authors:  Juliet Richards; Ai Chiin Lim; Colin W Hay; Angela E Taylor; Anna Wingate; Karolina Nowakowska; Carmel Pezaro; Suzanne Carreira; Jane Goodall; Wiebke Arlt; Iain J McEwan; Johann S de Bono; Gerhardt Attard
Journal:  Cancer Res       Date:  2012-03-12       Impact factor: 12.701

10.  Combination chemotherapy with 1-methyl-1-nitrosourea and cyclophosphamide in metastatic melanoma.

Authors:  K Kolarić; A Roth; V Fuss
Journal:  Tumori       Date:  1978-02-28
View more
  3 in total

1.  Pressure regulated basis for gene transcription by delta-cell micro-compliance modeled in silico: Biphenyl, bisphenol and small molecule ligand models of cell contraction-expansion.

Authors:  Hemant Sarin
Journal:  PLoS One       Date:  2020-10-06       Impact factor: 3.240

2.  Horizontal alignment of 5' -> 3' intergene distance segment tropy with respect to the gene as the conserved basis for DNA transcription.

Authors:  Hemant Sarin
Journal:  Future Sci OA       Date:  2016-12-02

3.  Inhibition of bcl-2 and cox-2 Protein Expression after Local Application of a New Carmustine-Loaded Clinoptilolite-Based Delivery System in a Chemically Induced Skin Cancer Model in Mice.

Authors:  Cristina Mihaela Ghiciuc; Aurel Lulu Strat; Lacramioara Ochiuz; Catalina Elena Lupusoru; Maria Ignat; Aurelia Vasile; Alexandru Grigorovici; Iulian Stoleriu; Carmen Solcan
Journal:  Molecules       Date:  2017-11-20       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.